The transition of medical students through residency: Effects on physical activity and other lifestyle-related behaviors

© 2016 Human Kinetics, Inc.Background: Little is known about lifestyle choices and preventive healthcare-seeking behaviors during the transition from medical school graduation to residency training, a period characterized by increased rates of stress and lack of free time due to demanding working conditions. All of these issues are likely to affect physical activity (PA) level. This study explored the evolution of PA and other lifestyle behaviors during this transition. Methods: A cross-sectional study and a cohort study were conducted with medical students (2010) and physicians before and after the first year of residency (2013 and 2014). A self-administered questionnaire assessed PA, health and lifestyle behaviors. Results: From a sample of 420 medical students and 478 residents, 74%comply with current PA guidelines. PA decreased by 16%during residency. Low levels of PA were found among (i) females and in respondents who reported (ii) poor self-perceived health and (iii) unhealthy body weight (P <.05). Low PA level was also significantly associated with poor mental health in first-year residents. Conclusions: The transition has a negative effect on physicians' PA level that may affect physicians' own health and patient care. Medical programs should encourage residents to engage in PA to assure physicians' personal and mental health

Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial

Terapia de inducción estándar; Volasertib adyuvante; Leucemia mieloide agudaStandard Induction Therapy; Adjunctive Volasertib; Acute Myeloid LeukemiaTeràpia d'inducció estàndard; Volasertib adjuvant; Leucèmia mieloide agudaIn this phase 3 trial, older patients with acute myeloid leukemia ineligible for intensive chemotherapy were randomized 2:1 to receive the polo-like kinase inhibitor, volasertib (V; 350 mg intravenous on days 1 and 15 in 4-wk cycles), combined with low-dose cytarabine (LDAC; 20 mg subcutaneous, twice daily, days 1–10; n = 444), or LDAC plus placebo (P; n = 222). Primary endpoint was objective response rate (ORR); key secondary endpoint was overall survival (OS). Primary ORR analysis at recruitment completion included patients randomized ≥5 months beforehand; ORR was 25.2% for V+LDAC and 16.8% for P+LDAC (n = 371; odds ratio 1.66 [95% confidence interval (CI), 0.95–2.89]; P = 0.071). At final analysis (≥574 OS events), median OS was 5.6 months for V+LDAC and 6.5 months for P+LDAC (n = 666; hazard ratio 0.97 [95% CI, 0.8–1.2]; P = 0.757). The most common adverse events (AEs) were infections/infestations (grouped term; V+LDAC, 81.3%; P+LDAC, 63.5%) and febrile neutropenia (V+LDAC, 60.4%; P+LDAC, 29.3%). Fatal AEs occurred in 31.2% with V+LDAC versus 18.0% with P+LDAC, most commonly infections/infestations (V+LDAC, 17.1%; P+LDAC, 6.3%). Lack of OS benefit with V+LDAC versus P+LDAC may reflect increased early mortality with V+LDAC from myelosuppression and infections.This study was funded by Boehringer Ingelheim

European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol

Risk stratification; Acute myeloid leukemiaEstratificació del risc; Leucèmia mieloide agudaEstratificación de riesgo; Leucemia mieloide agudaThe 2017 European LeukemiaNet (ELN 2017) guidelines for the diagnosis and management of acute myeloid leukemia (AML) have become fundamental guidelines to assess the prognosis and postremission therapy of patients. However, they have been retrospectively validated in few studies with patients included in different treatment protocols. We analyzed 861 patients included in the Cooperativo Para el Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias-12 risk-adapted protocol, which indicates cytarabine-based consolidation for patients allocated to the ELN 2017 favorable-risk group, whereas it recommends allogeneic stem cell transplantation (alloSCT) as a postremission strategy for the ELN 2017 intermediate- and adverse-risk groups. We retrospectively classified patients according to the ELN 2017, with 327 (48%), 109 (16%), and 245 (36%) patients allocated to the favorable-, intermediate-, and adverse-risk group, respectively. The 2- and 5-year overall survival (OS) rates were 77% and 70% for favorable-risk patients, 52% and 46% for intermediate-risk patients, and 33% and 23% for adverse-risk patients, respectively. Furthermore, we identified a subgroup of patients within the adverse group (inv(3)/t(3;3), complex karyotype, and/or TP53 mutation/17p abnormality) with a particularly poor outcome, with a 2-year OS of 15%. Our study validates the ELN 2017 risk stratification in a large cohort of patients treated with an ELN-2017 risk-adapted protocol based on alloSCT after remission for nonfavorable ELN subgroups and identifies a genetic subset with a very poor outcome that warrants investigation of novel strategies.This study was supported (in part) by Fondo de Investigaciones Sanitarias/Instituto de Salud Carlos III (ISCIII) grants PI16/01027, PI19/1476, and PI20/01621; Health Research and Innovation Strategic Plan (PERIS) grant SLT002/16/00433 and research group support SGR 1395 and SGR 1655 from Generalitat de Catalunya; resident award “Emili Letang” 2019 (Hospital Clínic de Barcelona); and “Beca de Investigación FEHH 2019” (Fundación Española de Hematologia y Hemoterapia)

Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1

Prognostic impact; Mutation; Acute myeloid leukemiaImpacte pronòstic; Mutació; Leucèmia mieloide agudaImpacto pronóstico; Mutación; Leucemia mieloide agudaThe negative prognostic impact of internal tandem duplication of FLT3 (FLT3-ITD) in patients with acute myeloid leukemia with mutated NPM1 (AML-NPM1) is restricted to those with a higher FLT3-ITD allelic ratio (FLT3high; ≥0.5) and considered negligible in those with a wild-type (FLT3WT)/low ITD ratio (FLT3low). Because the comutation of DNMT3A (DNMT3Amut) has been suggested to negatively influence prognosis in AML-NPM1, we analyzed the impact of DNMT3Amut in FLT3-ITD subsets (absent, low, and high ratios). A total of 164 patients diagnosed with AML-NPM1 included in 2 consecutive CETLAM protocols and with DNMT3A and FLT3 status available were studied. Overall, DNMT3Amut status did not have a prognostic impact, with comparable overall survival (P = .2). Prognostic stratification established by FLT3-ITD (FLT3WT = FLT3low > FLT3high) was independent of DNMT3Amut status. Measurable residual disease (MRD) based on NPM1 quantitative polymerase chain reaction was available for 94 patients. DNMT3Amut was associated with a higher number of mutated NPM1 transcripts after induction (P = .012) and first consolidation (C1; P < .001). All DNMT3Amut patients were MRD+ after C1 (P < .001) and exhibited significant MRD persistence after C2 and C3 (MRD+ vs MRD−; P = .027 and P = .001, respectively). Finally, DNMT3Amut patients exhibited a trend toward greater risk of molecular relapse (P = .054). In conclusion, DNMT3Amut did not modify the overall prognosis exerted by FLT3-ITD in AML-NPM1 despite delayed MRD clearance, possibly because of MRD-driven preemptive intervention.This work was supported in part by the Biomedical Research Institute (IIB Sant-Pau) and the José Carreras Leukemia Research Institute as well as grants from the Catalan Government (PERIS SLT002/16/0043 and AGAUR 2017 SGR 139) and the Instituto de Salud Carlos III, Ministerio de Economía y Competitividad, Spain (PI17/01246, PI20/01621 and CM20/00061)

Utilitat de la metodologia de simulació per adquirir competències en habilitats de comunicació

Podeu consultar la Vuitena trobada de professorat de Ciències de la Salut completa a: http://hdl.handle.net/2445/66524Metodología: Se describen los talleres y seminarios de simulación empleados desde el año académico 2010-11 en la Facultad de Medicina de la Universidad de Barcelona, que se ofrecen a los alumnos a partir de 2 año de grado, con el fin de ofrecer a los alumnos de forma transversal la adquisición y refuerzo continuo de competencias en habilidades de comunicación. Siguiendo las definiciones del Libro Blanco de las Facultades de Medicina y de la Guía de la Facultad de Medicina de la UB, se ofrece formación en los siguientes aspectos de la competencia de comunicación: • Escuchar con atención, obtener y sintetizar información pertinente acerca de los problemas que aquejan al enfermo, y comprender el contenido de esta información. • Comunicación de malas noticias • Obtener un consentimiento Informado • Comunicación entre profesionales Se describen el nivel de aprendizaje, el personal docente requerido, la duración de los seminarios o talleres, los objetivos docentes, el material necesario en cada actividad y el año de la formación de grado en que se aplica. Se describe la utilización de la estrategia de feed-back para la autoevaluación de la actividad práctica, empleando grabaciones de los talleres y simulaciones de los grupos de alumnos. Se describe así mismo, las encuestas empleadas para la evaluación por el docente y los compañeros de clase de las actividades de simulación y la metodología empleada de evaluación de los seminarios y su calificación dentro de la nota final de cada asignatura. Finalmente se describen las asignaturas optativas existentes en la Facultad de Medicina de la UB para reforzar las habilidades de comunicación y los planes futuros de desarrollo de actividades formativas complementarias y de refuerzo y las propuestas evaluativas de la competencia

Control design and parameter tuning for islanded microgrids by combining different optimization algorithms

Load and supply parameters may be uncertain in microgrids (MGs) due for instance to the intermittent nature of renewable energy sources among others. Guaranteeing reliable and stable MGs despite parameter uncertainties is crucial for their correct operation. Their stability and dynamical features are directly related to the controllers’ parameters and power-sharing coefficients. Hence, to maintain power good quality within the desirable range of system parameters and to have a satisfactory response to sudden load changes, careful selection of the controllers and power-sharing coefficients are necessary. In this paper, a simple design approach for the optimal design of controllers’ parameters is presented in an islanded MG. To that aim, an optimization problem is formulated based on a small-signal state-space model and solved by three different optimization techniques including particle swarm optimization (PSO), genetic algorithm (GA), and a proposed approach based on the combination of both PSO and GA. The optimized coefficients are selected to guarantee desirable static and dynamic responses in a wide range of operations regardless of the number of inverters, system configuration, output impedance differences, and load types. Through the proposed design and tuning method, the performance of the MG is improved as compared to those obtained using state-of-art techniques. This fact is demonstrated by using numerical simulations performed on a detailed model implemented in PSIM© software

Acknowledging and citing core facilities Key contributions to data lifecycle should be recognised in the scientific literature

Core facilities play a central role in the life sciences by generating data and ensuring quality standards. Their contributions to research should be appropriately acknowledged or cited in research papers.Non peer reviewe